FDA issues Biocon Form 483 with 12 observations
Following a pre-approval inspection of Biocon’s facilities in Malaysia, the US FDA issues 12 observations through a Form 483.
Archives for July 9, 2019
Bayer invests $215m as Century advances cell therapy programs
Century Therapeutics advances its allogeneic cell therapy platform created programs to the clinic after a $250m in financing led by Bayer.